O35 Timing of thromboembolic events in systemic lupus erythematosus associated to antiphospholipid syndrome; results from a population-based study set in Norway

• Øyvind Molberg,
• Sella A Provan,
• Karoline Lerang,
• Cathrine Brunborg,
• Hilde Haukeland,
• Sigrid R Moe,
• Torild Garen,
• Antonela Botea,
• Anniken Orre,
• Heidi Øvreås,
• Thea Bøe,
• Gro Å Wivestad,
• Nenad Damjanic

Affiliations

Øyvind Molberg

3Dept. of Rheumatology, Oslo University Hospital, Oslo, Norway

Sella A Provan

Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway

Karoline Lerang

Department of Rheumatology, Oslo University Hospital, Oslo, Norway

Cathrine Brunborg

10Oslo Centre for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital, Oslo, Norway

Hilde Haukeland

3Dept. of Rheumatology, Martina Hansens Hospital, Gjettum, Norway

Sigrid R Moe

1Dept. of Rheumatology, Oslo University Hospital, Oslo, Norway

Torild Garen

1Dept. of Rheumatology, Oslo University Hospital, Oslo, Norway

Antonela Botea

4Dept. of Rheumatology, Betanien Hospital, Skien, Norway

Anniken Orre

5Dept. of Rheumatology, Vestre Viken Hospital Trust, Drammen, Norway

Heidi Øvreås

6Dept. of Rheumatology, Lillehammer Hospital for Rheumatic Diseases, Lillehammer, Norway

Thea Bøe

7Dept. of Internal Medicine, Vestfold Hospital Trust, Tonsberg, Norway

Gro Å Wivestad

8Division of Rheumatology, Dept. of Medicine, Hospital of Southern Norway Trust, Kristiansand, Norway

Nenad Damjanic

9Dept. of Rheumatology, Ostfold Hospital Trust, Graalum, Norway